Warfarin-induced skin necrosis.
Moll
Stephan
S
Department of Medicine, Division of Hematology-Oncology, UNC School of Medicine, Chapel Hill, NC, USA. smoll@med.unc.edu
D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001940:Breast; D062109:Dermatologic Surgical Procedures; D005165:Factor V / Q000032:analysis; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009336:Necrosis; D011655:Pulmonary Embolism / Q000097:blood / Q000188:drug therapy / Q000473:pathology; D012867:Skin / Q000187:drug effects / Q000473:pathology*; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
D000925:Anticoagulants; C095381:factor V Leiden; D014859:Warfarin; D005165:Factor V; D006493:Heparin